Status:
UNKNOWN
Partially Covered Metal Stents Efficacy in Biliary Drainage of Malignant Extra-hepatic Biliary Obstruction
Lead Sponsor:
Santi Mangiafico
Conditions:
Biliary Obstruction
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Malignant obstructions of the bile duct are not rare. The most common and accepted method for biliary drainage is endoscopic stent placement. There are three types of metal stents: fully covered (FC),...
Detailed Description
Malignant obstructions of the bile duct are generally caused by: adenocarcinoma of the Vater ampulla, pancreas head cancer, cholangiocarcinoma and external compression secondary to lymph node (LN) met...
Eligibility Criteria
Inclusion
- •The patients who had malignant biliary obstruction with a estimated survival \>4 months
Exclusion
- The patients who had resectable biliary malignancy
- The patients who had hilar obstruction
- The patients who had duodenal obstruction
- The patients who had International Normalized Ratio (INR)\>1.5
- The patients who did not give informed consent
- The patients who had technically difficult structure for Endoscopic retrograde cholangiopancreatography (ERCP)
Key Trial Info
Start Date :
February 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2022
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT04431427
Start Date
February 1 2021
End Date
August 1 2022
Last Update
January 20 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.